Selected Publications

(2012)

 

Bensi G., Mora M., Tuscano G., Biagini M., Chiarot E., Bombaci M., Capo S., Falugi F., Manetti AG., Donato P., Swennen E., Gallotta M., Garibaldi M., Pinto V., Chiappini N., Musser JM., Janulczyk R., Mariani M., Scarselli M., Telford JL., Grifantini R., Norais N., Margarit I., Grandi G. (2012) Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case..  Mol Cell Proteomics. (abstract)

 

De Nicola, S., Aghemo, A., Grazia Rumi, M., Galmozzi, E., Valenti, L., Soffredini, R., De Francesco, R., Prati, G. M., D'Ambrosio, R., Cheroni, C., Donato, M. F., and Colombo, M. (2012) Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4, Hepatology 55, 336-342.

 


(2011)

 

Marabita, F., Aghemo, A., De Nicola, S., Rumi, M. G., Cheroni, C., Scavelli, R., Crimi, M., Soffredini, R., Abrignani, S., De Francesco, R., and Colombo, M. (2011) Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection, Hepatology 54, 1127-1134.


Galeotti CL, Bove E, Pezzicoli A, Nogarotto R, Norais N, Pileri S, Lelli B, Falugi F, Balloni S, Tedde V, Chiarot E, Bombaci M, Soriani M, Bracci L, Grandi G, Grifantini R. (2011) Surface interactome in Streptococcus pyogenes.  Mol Cell Proteomics. (abstract)

 

Rossi RL., Rossetti G., Wenandy L., Curti S., Ripamonti A., Bonnal RJP., Sciarretta BR., Moro M., Crosti MC., Gruarin P., Maglie S., Marabita F., Mascheroni D., Parente V., Comelli M., Trabucchi E., De Francesco R., Geginat J., Abrignani S., Pagani M. (2011) Distinct microRNA signatures in human lymphocyte subsets and enforcement of T cell naïve state by miR-125b. Nature Immunol. 12, 796 (abstract)


Celona B., Weiner A., Di Felice F., Mancuso FM., Cesarini E., Rossi RL., Gregory L., Baban D., Rossetti G., Grianti P., Pagani M., Bonaldi T., Ragoussis J., Friedman N.,Camilloni G., Bianchi ME., Agresti A. (2011)  Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol. June;9(6):e1000582 (abstract)

 

Bosè F., Raeli L., Garutt C., Frigerio E., Cozzi A., Crimi M., Caprioli F., Scavelli R., Altomare G., Abrignani S., Reali E. (2011) Anti-TNF therapy enhances peripheral T cell responses to TCR stimulation while inhibiting T cell cytokine gene expression in inflammed tissue. Clin Immunol. 139, 164. (abstract)




(2010)


Bombaci M., Grifantini R. (2010) Protein microarrays applications in biological and medical research. Chapter Book: New Research Trends in Protein Chip Technology, 1, 24  Transworld Research Network. (abstract)

Abrignani, S., De Francesco, R., and Houghton, M. (2010) Vaccination against hepatitis C virus, In New Generation Vaccines (Levine, M. M., Dougan, G., Good, M. F., Liu, M. A., Nabel, G. J., Nataro, J. P., and Rappuoli, R., Eds.) 4th ed., Informa Healthcare, New York.



(2009)

Bombaci M., Grifantini R., Mora M., Reguzzi V., Petracca R., Balloni S., Meoni E., Zingaretti C., Falugi F., , Margarit I., Musser JM., Cardona F., Orefici G., Grandi G.  Bensi G. (2009) Protein array profiling of human sera unravels the link between group A Streptococcus and tic disorder. PLoS One 4(7):e6332  (abstract)


Margarit I., Bonacci S., Pietrocola G., Rindi S., Ghezzo C., Bombaci M., Nardi-Dei V., Grifantini R., Speziale P., Grandi G. (2009) Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen and C4BP. FASEB J. 23, 3100 (abstract)



Conte I., Giuliano C., Ercolani C., Narjes F., Koch U., Rowley M., Altamura S., De Francesco R., Neddermann P., Migliaccio G., Stansfield I. (2009) Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture Bioorg Med Chem Lett. 19, 1779 (abstract)




(2008)

Zeytin H., Reali E., Zaharoff D.A., Rogers C.J., Schlom J., Greiner J.W. (2008) Targeted delivery of murine Interferon-g using a recombinant Fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.  J. Interferon Cytokine Res. 28, 73 (abstract)


Reali, E., Houghton, M., Abrignani, S. (2008)  Chapter Book: Vaccination against the hepatitis C virus. In: Plotkin SA Ed. Vaccines 5th Edition, 47, 1187 (abstract)


Scavelli R., Abrignani S., Crimi M. (2008) Chapter Book: Oligonucleotide Array Sequence Analysis. In: Oncology applications of microarray technology detecting small genomes variability. Moretti KM and  Rizzo L J.  18, 457 (abstract)


Tonti E., Galli G., Malzone C., Abrignani S., Casorati G., Dellabona P. (2008) NKT cell help to B lymphocytes can occur independently of cognate interaction. Blood. 113, 370 (abstract)


Serra A., Nuti S., Tavarini S., Sammicheli C., Rosa D., Saletti G., Soldaini E., Abrignani S., Wack A. (2008) Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector function. J Immunol. 181, 174 (abstract)


Cecconi V., Moro M., Del Mare S., Dellabona P., Casorati G. (2008) Use of MHC Class II tetramers to investigate CD4+ T cell responses: problems and solutions. Cytometry. 73, 1010 (abstract)


Crimi M., Rigolio R. (2008) The mitochondrial genome, a growing interest inside an organelle. Int J Nanomedicine. 3,  51 (abstract)




(2007)

Galli G., Pittoni P., Tonti E., Malzone C., Uematsu Y., Tortoli M., Maione D., Volpini G., Finco O., Nuti S., Tavarini S., Dellabona P., Rappuoli R., Casorati G., Abrignani S. (2007) Invariant NKT cells sustain specific B cell responses and memory. Proc Natl Acad Sci USA 104, 3984 (abstract)




(2006)

Brazzoli M., Crotta S., Bianchi A., Bagnoli F., Monaghan P., Wileman T., Abrignani S., Merola M. (2006) Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line. J Hepatol. 46, 53 (abstract)


Vajdy M., Selby M., Medina-Selby A., Coit D., Hall J., Tandeske L., Chien D., Hu C., Rosa D.,Singh M., Kazzaz J., Nguyen S., Coates S., Ng P., Abrignani S., Lin YL., Houghton M., DTO'Hagan. (2006) Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses. J Gen Virol. 87, 2253 (abstract)


Crotta S., Ronconi V., Ulivieri C., Baldari CT., Valiente NM., Abrignani S., Wack A. (2006) Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells. Eur J Immunol.  36, 919 (abstract)




(2005)

Rosa D., Saletti G., De Gregorio E., Zorat F., Comar C., D'Oro U., Nuti S., Houghton M., Barnaba V., Pozzato G., Abrignani S. (2005) Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A 102, 18544 (abstract)


Kong WP., Xu L., Stadler K., Ulmer JB., Abrignani S., Rappuoli R,.  Nabel GJ. (2005) Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization. J Virol.  79, 13915 (abstract)


Stadler K., Roberts A., Becker S., Vogel L., Eickmann M., Kolesnikova L., Klenk HD., Murphy B., Rappuoli R., Abrignani S., Subbarao K. (2005) SARS vaccine protective in mice. Emerg Infect Dis.  11, 1312 (abstract)


Houghton M., Abrignani S. (2005) Prospects for a vaccine against the hepatitis C virus. Nature 436, 961 (abstract)